Table 5 Summary of participant visits

From: A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults

Group

Participants (n)

Visit time points

Scr.

M0

M1

M2

M3

M6

D0

D1

D2

D7

D0

D1

D2

D7

D0

D1

D2

D7

D0

D0

1

50

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

2

50

x

x

  

x

x

  

x

x

  

x

x

x

3

20

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

  1. Group 1 = R21/Matrix-M™ + DHA-PIP + SLD-PQ n = 50, Group 2 = R21/Matrix-M™ n = 50, Group 3 = No vaccine n = 20.
Back to article page